Navigate this market better. Subscribe for FREE stock alerts and information.

Thursday, February 12, 2015

Valeant secures financing for potential Salix bid - Bloomberg, (NASDAQ: SHPG), (NASDAQ: SLXP), (NYSE: VRX), (TSE: VRX.TO)

Canada's Valeant Pharmaceuticals International Inc has arranged financing for a potential takeover bid for bowel-drug maker Salix Pharmaceuticals Ltd, Bloomberg reported, citing people familiar with the matter. Valeant will likely bid more than $150 per share for the company, Bloomberg said, quoting one of those people. (bloom.bg/16YHzmJ)A bid of $150 per share would value Salix at about $9.6 billion. Salix's stock was up 4.6 percent at $149.82 in afternoon trading on the Nasdaq on Thursday.Salix, based in Raleigh, North Carolina, was not immediately available for comment. A Valeant spokeswoman said the company does not respond to market rumors or speculation.Bloomberg, citing sources, reported earlier this month that British drugmaker Shire Plc was also interested in Salix. (bloom.bg/1Da0N5B)

Shire plc (Shire) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shares of SHPG traded higher by 5.01% or $10.93/share to $229.11. In the past year, the shares have traded as low as $141.66 and as high as $264.98. On average, 947668 shares of SHPG exchange hands on a given day and today's volume is recorded at 1286070.

Salix Pharmaceuticals, Ltd. is a specialty pharmaceutical company engaged in the prevention and treatment of gastrointestinal (GI) disorders. Shares of SLXP traded higher by 3.98% or $5.71/share to $149.05. In the past year, the shares have traded as low as $86.00 and as high as $172.98. On average, 1889100 shares of SLXP exchange hands on a given day and today's volume is recorded at 2719576.

Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 1.85% or $3.04/share to $167.38. In the past year, the shares have traded as low as $106.00 and as high as $165.69. On average, 2109400 shares of VRX exchange hands on a given day and today's volume is recorded at 2183900.

Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 0.47% or $0.98/share to $208.77. In the past year, the shares have traded as low as $116.01 and as high as $208.61. On average, 439306 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 285763.



Source